Topic: genetic engineering
Mekonos aims to use silicon nanoneedles to deliver genetic payloads directly into the cell using a purely physical, mechanical form factor, with the goal of greatly lowering the cost and time of developing cell therapies.
Feng Zhang's latest CRISPR company, Beam Therapeutics, officially came out of stealth Monday with $87 million in series A funding.
Scientists at Rice University say they have created a toolkit of gene “promoters” that can turn genes on and off at command.
MIT scientists have devised a gene circuit that could identify cancer cells more accurately and stimulate the immune system more effectively.